These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11230446)

  • 1. Yield of vancomycin-resistant enterococci and multidrug-resistant Enterobacteriaceae from stools submitted for Clostridium difficile testing compared to results from a focused surveillance program.
    Hacek DM; Bednarz P; Noskin GA; Zembower T; Peterson LR
    J Clin Microbiol; 2001 Mar; 39(3):1152-4. PubMed ID: 11230446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory-based surveillance for vancomycin-resistant enterococci: utility of screening stool specimens submitted for Clostridium difficile toxin assay.
    Leber AL; Hindler JF; Kato EO; Bruckner DA; Pegues DA
    Infect Control Hosp Epidemiol; 2001 Mar; 22(3):160-4. PubMed ID: 11310695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three surveillance strategies for vancomycin-resistant enterococci in hospitalized patients: detection of colonization efficiency and a cost-effectiveness model.
    Lee TA; Hacek DM; Stroupe KT; Collins SM; Peterson LR
    Infect Control Hosp Epidemiol; 2005 Jan; 26(1):39-46. PubMed ID: 15693407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of vancomycin-resistant enterococci (VRE) in stool specimens submitted for Clostridium difficile toxin testing.
    Özsoy S; İlki A
    Braz J Microbiol; 2017; 48(3):489-492. PubMed ID: 28389190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications for vancomycin-resistant Enterococcus colonization associated with Clostridium difficile infections.
    Fujitani S; George WL; Morgan MA; Nichols S; Murthy AR
    Am J Infect Control; 2011 Apr; 39(3):188-93. PubMed ID: 21458682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active surveillance for carbapenem-resistant Enterobacteriaceae, vancomycin-resistant enterococci and toxigenic Clostridium difficile among patients transferred from long-term care facilities in Korea.
    Hwang JH; Park JS; Lee E; Bae JY; Song KH; Choe PG; Park WB; Bang JH; Kim ES; Park SW; Kim NJ; Oh M; Kim HB
    J Hosp Infect; 2018 Aug; 99(4):487-491. PubMed ID: 29476883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the ChromID ESBL agar for the detection of ESBL-positive Enterobacteriaceae and vancomycin-resistant enterococcus isolates from urine cultures].
    Alışkan HE; Colakoğlu S; Turunç T; Demiroğlu YZ
    Mikrobiyol Bul; 2012 Jan; 46(1):17-25. PubMed ID: 22399167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contamination of the clinical microbiology laboratory with vancomycin-resistant enterococci and multidrug- resistant Enterobacteriaceae: implications for hospital and laboratory workers.
    Collins SM; Hacek DM; Degen LA; Wright MO; Noskin GA; Peterson LR
    J Clin Microbiol; 2001 Oct; 39(10):3772-4. PubMed ID: 11574615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile and vancomycin-resistant enterococcus: the new nosocomial alliance.
    Poduval RD; Kamath RP; Corpuz M; Norkus EP; Pitchumoni CS
    Am J Gastroenterol; 2000 Dec; 95(12):3513-5. PubMed ID: 11151886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin-resistant enterococci in stool specimens submitted for Clostridium difficile cytotoxin assay.
    Rafferty ME; McCormick MI; Bopp LH; Baltch AL; George M; Smith RP; Rheal C; Ritz W; Schoonmaker D
    Infect Control Hosp Epidemiol; 1997 May; 18(5):342-4. PubMed ID: 9154478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Undetected vancomycin-resistant Enterococcus stool colonization in a Veterans Affairs Hospital using a Clostridium difficile-focused surveillance strategy.
    Ray AJ; Hoyen CK; Das SM; Eckstein EC; Donskey CJ
    Infect Control Hosp Epidemiol; 2002 Aug; 23(8):474-7. PubMed ID: 12186217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for vancomycin-resistant enterococci using stools sent for Clostridium difficile cytotoxin assay is effective: results of a survey of 300 Patients in a large Singapore Teaching Hospital.
    Tay JK; Bodle EE; Fisher DA; Lin RV; Kumarasinghe G; Tambyah PA
    Ann Acad Med Singap; 2007 Nov; 36(11):926-9. PubMed ID: 18071603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of multifaceted versus Clostridium difficile-focused VRE surveillance strategies in a low-prevalence setting.
    Katz KC; Gardam MA; Burt J; Conly JM
    Infect Control Hosp Epidemiol; 2001 Apr; 22(4):219-21. PubMed ID: 11379713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia.
    Roghmann MC; McCarter RJ; Brewrink J; Cross AS; Morris JG
    Clin Infect Dis; 1997 Nov; 25(5):1056-9. PubMed ID: 9402356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Rodac imprint method to selective enrichment broth for recovery of vancomycin-resistant enterococci and drug-resistant Enterobacteriaceae from environmental surfaces.
    Hacek DM; Trick WE; Collins SM; Noskin GA; Peterson LR
    J Clin Microbiol; 2000 Dec; 38(12):4646-8. PubMed ID: 11101613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force.
    Weber SG; Huang SS; Oriola S; Huskins WC; Noskin GA; Harriman K; Olmsted RN; Bonten M; Lundstrom T; Climo MW; Roghmann MC; Murphy CL; Karchmer TB
    Am J Infect Control; 2007 Mar; 35(2):73-85. PubMed ID: 17327185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of Clostridioides difficile and multidrug-resistant healthcare-associated pathogens in stool specimens from hospitalized patients in the USA.
    Tickler IA; Dela Cruz CM; Obradovich AE; Goering RV; Dewell S; Le VM; Tenover FC;
    J Hosp Infect; 2020 Sep; 106(1):179-185. PubMed ID: 32649974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the assessment of vancomycin-resistant enterococci by routine screening.
    Huang SS; Rifas-Shiman SL; Pottinger JM; Herwaldt LA; Zembower TR; Noskin GA; Cosgrove SE; Perl TM; Curtis AB; Tokars JL; Diekema DJ; Jernigan JA; Hinrichsen VL; Yokoe DS; Platt R;
    J Infect Dis; 2007 Feb; 195(3):339-46. PubMed ID: 17205471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance for vancomycin-resistant enterococci: type, rates, costs, and implications.
    Shadel BN; Puzniak LA; Gillespie KN; Lawrence SJ; Kollef M; Mundy LM
    Infect Control Hosp Epidemiol; 2006 Oct; 27(10):1068-75. PubMed ID: 17006814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the BD GeneOhm VanR assay to culture for identification of vancomycin-resistant enterococci in rectal and stool specimens.
    Stamper PD; Cai M; Lema C; Eskey K; Carroll KC
    J Clin Microbiol; 2007 Oct; 45(10):3360-5. PubMed ID: 17704282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.